Evidence map›Paper›PMID 38696410›Full record

ArticlePloS one2024

A cautionary tale about properly vetting datasets used in supervised learning predicting metabolic pathway involvement.

Erik D Huckvale, Hunter N B Moseley

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Erik D HuckvaleMarkey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America.
Hunter N B MoseleyMarkey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America.ORCID 0000-0003-3995-5368

Funding

Vascular Mechanisms of PCB-Induced Brain MetastasesP42ES007380 · NIEHS · UNIVERSITY OF KENTUCKY · PI MORRIS, ANDREW J · 1997 to 2024
$47.8M
NIEHS NIH HHS P42 ES007380
6 · The paper itself

Abstract

The mapping of metabolite-specific data to pathways within cellular metabolism is a major data analysis step needed for biochemical interpretation. A variety of machine learning approaches, particularly deep learning approaches, have been used to predict these metabolite-to-pathway mappings, utilizing a training dataset of known metabolite-to-pathway mappings. A few such training datasets have been derived from the Kyoto Encyclopedia of Genes and Genomes (KEGG). However, several prior published machine learning approaches utilized an erroneous KEGG-derived training dataset that used SMILES molecular representations strings (KEGG-SMILES dataset) and contained a sizable proportion (~26%) duplicate entries. The presence of so many duplicates taint the training and testing sets generated from k-fold cross-validation of the KEGG-SMILES dataset. Therefore, the k-fold cross-validation performance of the resulting machine learning models was grossly inflated by the erroneous presence of these duplicate entries. Here we describe and evaluate the KEGG-SMILES dataset so that others may avoid using it. We also identify the prior publications that utilized this erroneous KEGG-SMILES dataset so their machine learning results can be properly and critically evaluated. In addition, we demonstrate the reduction of model k-fold cross-validation (CV) performance after de-duplicating the KEGG-SMILES dataset. This is a cautionary tale about properly vetting prior published benchmark datasets before using them in machine learning approaches. We hope others will avoid similar mistakes.

Indexed as

Metabolic Networks and PathwaysSupervised Machine LearningDatasets as TopicHumans

Identifiers

PMID38696410
PMCPMC11065254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.